Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 12, Pages 1619-1635
Publisher
Informa Healthcare
Online
2014-07-25
DOI
10.1517/13543784.2014.942728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroendocrine Tumors
- (2017) Journal of the National Comprehensive Cancer Network
- Treatment of Cushing disease: overview and recent findings
- (2016) Andrea Giustina Therapeutics and Clinical Risk Management
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Biotherapies for GEP-NETs
- (2013) Kjell Öberg BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Emerging drugs for acromegaly
- (2013) Sylvère Störmann et al. EXPERT OPINION ON EMERGING DRUGS
- Investigational therapies for acromegaly
- (2013) Ludovica FS Grasso et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Octreotide for acromegaly treatment: a reappraisal
- (2013) Andrea Giustina et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly
- (2013) Carla Chieffo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective Study
- (2013) G. Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Improving the Success Rate of Gluteal Intramuscular Injections
- (2013) April E. Boyd et al. PANCREAS
- Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
- (2013) Stephan Petersenn et al. Pituitary
- PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
- (2012) F. Meric-Bernstam et al. CLINICAL CANCER RESEARCH
- A Subcutaneous Octreotide Hydrogel Implant for the Treatment of Acromegaly
- (2012) Mônica Gadelha et al. Endocrine Practice
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
- (2012) Larry K Kvols et al. ENDOCRINE-RELATED CANCER
- Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study
- (2012) H. Dietrich et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide
- (2012) Laleh Erfani Jabarian et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
- (2012) S. Tuvia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
- (2012) Marianne Pavel et al. NEUROENDOCRINOLOGY
- A consensus on the diagnosis and treatment of acromegaly complications
- (2012) S. Melmed et al. Pituitary
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours
- (2011) U Plöckinger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Somatostatin-Dopamine Chimeras: A Novel Approach to Treatment of Neuroendocrine Tumors
- (2011) M. Culler HORMONE AND METABOLIC RESEARCH
- First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical, quality of life, and economic value of acromegaly disease control
- (2011) A. Ben-Shlomo et al. Pituitary
- Oral delivery of octreotide acetate in Intravail® improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss Webster mice
- (2011) Edward T. Maggio et al. REGULATORY PEPTIDES
- Diabetes in Cushing syndrome: basic and clinical aspects
- (2011) Gherardo Mazziotti et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
- (2010) V. Cerovac et al. CANCER RESEARCH
- Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
- (2010) Kjell E. Öberg et al. GASTROENTEROLOGY
- OR14,80 Octreolin™, a safe oral alternative for parenteral octreotide treatment
- (2010) S. Tuvia et al. GROWTH HORMONE & IGF RESEARCH
- Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial
- (2010) S. Petersenn et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Current management practices for acromegaly: an international survey
- (2010) A. Giustina et al. Pituitary
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Lung tumours with neuroendocrine differentiation
- (2009) William D. Travis EUROPEAN JOURNAL OF CANCER
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Guidelines for Acromegaly Management: An Update
- (2009) S. Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
- (2009) M. Breuleux et al. MOLECULAR CANCER THERAPEUTICS
- Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
- (2009) Roberto Salvatori et al. Pituitary
- Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
- (2008) A. Moreno et al. ENDOCRINE-RELATED CANCER
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Somatostatin–dopamine ligands in the treatment of pituitary adenomas
- (2008) Alexandru Saveanu et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Pasireotide (SOM230): Development, mechanism of action and potential applications
- (2007) Herbert A. Schmid MOLECULAR AND CELLULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started